Jeena Sikho Lifecare Limited (JSLL)
Jeena Sikho Lifecare Limited has informed the Exchange regarding the Investor Presentation.
Investor Presentation - Q1FY27
- Revenue from Operations grew 29% YoY to ₹224.4 Cr, EBITDA up 17% YoY with 41% margin
- Ayurveda Products segment grew 47% YoY; Services segment saw 13% YoY growth in Panchkarma revenue
- IPD patient volumes increased 33% YoY; Day care volumes rose 31% YoY to 19,419 per day
- Operational beds at 2,400 with 450 beds in pipeline; continued network expansion planned
- Strong operating leverage and scalability driving profitability improvements
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 JSLL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add JSLL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Jeena Sikho Lifecare Limited
Important.
The summary above is generated automatically from Jeena Sikho Lifecare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.